Contraceptives, hormonal

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Hormone preparations for contraception. They are classified as follows:
  • Single-phase preparations (Pinkus Pill): Constant concentration of estrogen and progestin from the 5th to 25th day of the cycle, then a 7-day break; inhibition of ovulation by suppressing gonadotropin secretion, alteration of the cervical mucus (sperm ascension is inhibited), alteration of the endometrium. Pearl index: 0.
  • Two-phase preparations: In the first half of the cycle, an estrogen alone or in combination with a low-dose progestin dose is taken, in the second half an estrogen-progestin mixture with a high progestin content; ovulation inhibition by suppressing gonadotropin secretion. Pearl index: 0,5-1.
  • Three-phase preparations: In order to make the normal cycle more regular, estrogens and progestins are taken in three phases at different doses.
  • Minipill: Continuous intake of a low-dose progestin; change in cervical mucus, no inhibition of ovulation.
  • Depot preparations: I.m. Injection of a depot progestogen, usually medroxyprogesterone acetate, in a dose of 150 mg every 3 months; inhibition of gonadotropin secretion, affecting the cervical mucus and endometrium. Pearl index: 0.3-1.5.
  • Morning after pill: post-coital (24-48 hrs p.c.) high doses of oestrogen (5 mg) are given for 3-5 days; inhibition of implantation of the fertilized egg.

Undesirable effectsThis section has been translated automatically.

Estrogen-related: hypermenorrhea, edema tendency, nausea, varicose veins, fluoride Progestin-related: hypermenorrhea, depression, loss of libido, increased appetite, seborrhea, acne, increased blood pressure. See also progestins, estrogens, estrogen-progestin combinations.

Authors

Last updated on: 29.10.2020